Objective: The aim of this study is to evaluate the mediastinal lymph node (MLN) metastasis comparatively with Tc99m-MIBI SPECT scintigraphy, thoracic computed tomography (CT), and video-mediastinoscopy (VM) in the staging of non-small cell lung cancer (NSCLC).
INTRODUCTION
The most important factor affecting the treatment type and prognosis in non-small cell lung cancer (NSCLC) is whether or not mediastinal lymph node (MLN) metastasis is present (1, 2) . Clinically, the examination of MLN metastasis mostly depends on the imaging methods, but they have no reliable rates alone (3) . Today, direct radiography, computed tomography (CT), and magnetic resonance imaging are non-invasive methods that are selected for the evaluation of the tumor in the lung. However, these methods have limited value in determining the nature of suspicious lung nodules, evaluating mediastinal involvement and also the tumor viability (4) . Various radionuclide substances such as 67 Ga, 201Tl, and 99mTc-tetrofosmin, 99mTc-MIBI (technetium 99m hexakis 2-methoxy isobutyl isonitrile), and 18F-fluorodeoxyglucose are used in NSCLC staging, treatment response, and follow-up (4) (5) (6) . The aim of this study is to evaluate the mediastinal lymph nodes (MLN) comparatively by using video-mediastinoscopy (VM), 99mTc-MIBI SPECT scintigraphy, and thoracic CT in the staging of NSCLC.
MATERIALS and METHODS
Forty consecutive patients, 36 men and 4 women between the ages of 43 and 75 years (average age 59.3 SD±8.75 years), for whom resection was planned due to NSCLC, were included in this prospective study (2008) (2009) ). An assessment of MLN with 99mTc-MIBI SPECT scintigraphy before VM was conducted in all the patients who were proven as operable via physical examination, blood count, biochemistry, blood gas, respiratory function tests, bronchoscopy, bone scanning, and contrast whole-body CT scanning. To obtain a definitive diagnosis, techniques such as transthoracic biopsy, cytology, bronchoscopy, VM, and thoracotomy were used. The MLN biopsies were done in all patients by VM. Thoracotomy and MLN dissection were conducted in those patients who did not have MLN metastasis. None of the patients received chemotherapy or radiotherapy before the operation. Thoracic CT, 99mTc-MIBI SPECT scintigraphy, and MLN pathology results were comparatively evaluated by means of statistical analysis. Prior to the inclusion of patients in the study, the ethics committee approval and patient informed consent form were obtained (Decision no: 249).
99mTc-MIBI SPECT Protocol: 20 mCi 99mTc-MIBI was intravenously administered to the patients. SPECT data were collected 20 minutes after the injection by using a double-head right-angled gamma camera (ECAM; Siemens, Erlangen, Germany) with a widearea image. For SPECT images, Butterworth filtering (0.43/7) was used. The 99mTc-MIBI images were qualitatively and quantitatively evaluated as follows: 1) In the qualitative analysis, when an increased activity involvement was determined in one or more areas of the lung, the SPECT was accepted as positive. MLN involvement was evaluated when there were one or more foci of well-defined increased 99mTc-MIBI uptake in the mediastinum, compared with the background activity. 2) In the quantitative analysis, the highest area of the involvement on the tumor was marked, and the opposite side was marked by using the mirror image technique at the same size in normal lung. The 99mTc-MIBI uptake values of the mediastinal lymph nodes were compared separately, both with the background mediastinal tissue and the contralateral MLN detected via the mirror image technique.
The mean activity counts of the tumor mass were divided by the mean activity counts of the normal lung on the opposite side so that the tumor involvement rate (Tumor/Normal lung involvement rate, T/N) could be calculated. The mean activity counts of the lymph node were divided by the mean activity counts of the background mediastinum so that the mediastinal lymph node/ normal mediastinum involvement rate (MLN/Nm ratio) could be calculated. Then, the high MLN/Nm ratio was divided by the low MLN/Nm ratio to compare 99mTc-MIBI uptake values of the both sides' lymph nodes and to create the term of MLN ratio. Via the MLN ratio, we aimed to detect the difference between the MIBI involvement in metastatic MLN and MIBI involvement in reactive or anthracotic lymph nodes. An MLN ratio greater than 1 was considered as metastasis. Thus, the Region of Interest terms were developed to evaluate the increased activity involvement areas semi-quantitatively.
Statistical analysis
Statistical Package for the Social Sciences (SPSS) Windows version 15.0 (SPSS Inc.;Chicago, IL, USA) software package were used to evaluate the study data. Chi-square test was used to determine the difference between the variables. Mann-Whitney U test was used to examine the correlation between the SPECT results and other variables (age, gender, histological type). Kappa analysis was applied to specify the consistency power between the examinations. Pathological evaluation was accepted as the gold standard for the calculation of specificity and sensitivity. For all the statistical analyses, values of p<0.05 were accepted as statistically significant.
RESULTS
In the tomographic assessment, there was a mass in the right upper lobe in 42% (n=17), the right lower lobe in 25% (n=10), the left upper lobe in 18% (n=7), and the left lower lobe in 15% (n=6) of the patients. Malignancy was diagnosed by bronchoscopy in 55% (n=22) and by transthoracic fine-needle aspiration biopsy in 30% (n=12) of the patients. In 15% (n=6) of the patients with negative cytology, the diagnosis was made through thoracotomy.
Epidermoid carcinoma in 64% of the patients (n=26), adeno carcinoma in 28% (n=11), and large cell carcinoma in 8% (n=3) 
DISCUSSION
The method of MLN staging should have a high specificity and sensitivity in determining whether or not MLNs are metastatic. Genereux et al. (7) reported that 89% to 95% of normal lymph nodes were under 11 mm in size. As the size increases, the risk of lymph node metastasis also increases. However, in the literature, it was shown that 8% to 17% of normal-size lymph nodes were metastatic, and 30% of pathological-size lymph nodes were reactive (8, 9) . Thus, it may be faulty to evaluate the MLN enlargement as metastatic or reactive depending on the CT results and to define it as an inoperability criterion. Because CT evaluates only the size of the lymph node, it cannot differentiate the inflammatory disease-related lymph node enlargements from metastasis. In the literature, the sensitivity of thoracic CT was 20%-86%, specificity 50%-93%, PPV 26%-86%, and NPV 40%-93% (10, 11) . In this study, the sensitivity of thoracic CT was 33%, specificity 82.3%, PPV 25%, and NPV 87.5%. As seen from the study results and the literature review, despite the technological developments in thoracic CT, no significant change was observed in the sensitivity and specificity rates, and it is not a reliable method in MLN staging. Thus, the interest toward functional imaging methods has increased (12, 13). 99mTc-MIBI SPECT scintigraphy has a (12) both specified that 99mTc-MIBI SPECT had 100% specificity and PPV in determining the malignancies and was more specific than CT in determining N2-3 disease. Also, they argued that mediastinoscopy may not be necessary in patients with 99mTc-MIBI SPECT positive results. The results of 99mTc-MIBI SPECT in the literature regarding the determination of MLN metastasis are presented in Table 3 . In this study, MLN metastasis was detected correctly in 5 out of 6 patients with 99mTc-MIBI SPECT. The reason for the determination of low specificity and PPV was that 2 patients diagnosed with right-upper-lobe adeno carcinoma in this study had false positive results. Right upper lobectomy and MLN dissection were applied in these patients. However, the pathology reports of the MLN were as reactive as anthracotic lymph nodes. False positive results were obtained by MIBI SPECT in these patients (Figure 1 ). MLNs sometimes become larger or hyper-activated due to inflammation, and the accumulation of Tc-99m MIBI can also be detected in these inflammatory areas (22, 23) . However, benign nodes may also be enlarged because of reactive hyperplasia, anthracosis, inflammation, or infection (9) . The false positive results detected in 2 patients were based on the inflammation in reactive and anthracotic lymph nodes. Tc-99 m MIBI uptakes in MLN were calculated, and the mean MLN/Nm ratio was 2.1±0.66 SD (range 1.06-3.5). These values were containing MIBI uptake in all metastatic, reactive, and anthracotic lymph nodes. Because of this involvement, we analyze the MIBI SPECT results by semi-quantitative analysis according to the value of bilateral MLN ratio to exclude the Tc-99 m MIBI uptakes in reactive and anthracotic lymph nodes. There was only one 99mTc-MIBI SPECT false negative result in a 45-year-old female patient who was diagnosed with adeno carcinoma in the left lower lobe (Figure 2 ). Right no.2 MLN (N3) metastasis was determined through mediastinoscopy. Also MLN did not have pathological size in thoracic CT. The cause of errors in the scintigraphy assessment was investigated. Even though 99mTc-MIBI SPECT is an easily applied method, its interpretation is not always easy. It was very difficult to determine the number of MLNs showing the exact involvement, although 3D sections can be taken. There was no difficulty in determining an increased 99mTc-MIBI reuptake in various areas of mediastinum. However, it was not always possible to evaluate its correlation with the surrounding vein structures. Because anatomic margins cannot be exactly selected via SPECT, contrary to CT, lesion and large vein structures can be confused and thus false interpretations may occur.
In a meta-analysis including 5.687 cases, the sensitivity of VM was 84%, specificity 100%, false positive 0%, and false negative 9% (24) . The results of VM from this study are given in Table 2 . The most important factor that contributed to such high rates was that there was no false negative results in case of mediastinoscopy. The reason for this was that utmost effort was shown for taking biopsies from all the MLNs that can be seen by dissecting all the MLN stations routinely that can be reached during mediastinoscopy. 
Study limitations
The main limitation of this study was the low number of patients. This prospective study was planned as an expertise thesis. The time for the recruitment of patients was limited to only 1 year. Planning a long-term study can lead to wider outcomes, including subgroups of lung cancer, by increasing the number of patients.
CONCLUSION
Considering the results of this study and those described in the literature, despite the improvements in technology, the accuracy of thoracic CT in mediastinal staging of NSCLC patients has not reached the desired level. Although 99mTc-MIBI SPECT has high NPV, specificity, and sensitivity, considering the studies conducted until now, it is incorrect to assert that it will supersede mediastinoscopy. Even though mediastinoscopy is invasive, it is still the gold standard in staging MLN due to its high accuracy rates, easy application, and minimal morbidity and mortality rates.
Ethics Committee Approval: Ethics committee approval was received for this study from local ethics committee.
Informed Consent: Informed consent was obtained from patients who participated in this study.
Peer-review: Externally peer-reviewed.
Author Contributions: Conceived and designed the experiments or case: OO., OFD. Performed the experiments or case: OO., OFD. Analyzed the data: OO., OFD. Wrote the paper: OO., OFD. All authors have read and approved the final manuscript.
Conflict of Interest:
No conflict of interest was declared by the authors.
Financial Disclosure: The authors declared that this study has received no financial support. 
